Optical Coherence Tomography for Intraocular Tumors

Volume 35, Number # 3, 2007 Series

1. Shields JA, Shields CL. Intraocular Tumors: A Text and Atlas. Philadelphia: WB Saunders, 1992.

2. Shields JA, Shields CL. Atlas of Intraocular Tumors. Philadelphia, Lippincott Williams and Wilkins, 1999.

3. Sumich P, Mitchell P, Wang JJ. Choroidal nevi in a white population: the Blue Mountains Study. Arch Ophthalmol 1998; 116: 645-50.

4. Shields CL Shields JA, Kiratli H, Cater JR, De Potter P. Risk factors for growth and metastasis of small choroidal melanocytic lesions. Ophthalmology 1995;102:1351-61.

5. Shields CL, Cater JC, Shields JA, Singh AD, Santos MCM, Carvalho C. Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. Arch Ophthalmol 2000;118:360-4.

6. Shields CL, Demirci H, Materin MA, Marr BP, Mashayekhi A, Shields JA. Clinical factors in the identification of small choroidal melanoma. Can J Ophthalmol, 2004;39:351-7.

7. Shields CL, Mashayekhi A, Materin MA, Marr BP, Demirci H, Luo CK, Shields JA. Optical coherence tomography of choroidal nevus in 120 consecutive patients. Retina 2005;25:243-52

8. Espinoza G, Rosenblatt B, Harbour JW. Optical coherence tomography in the evaluation of retinal changes associated with suspicious chrooidal melanocytic tumors. Am J Ophthalmol 2004; 137: 90-5.

9. Shields JA, Shields CL, Donoso LA: Management of posterior uveal melanomas. Surv Ophthalmol 1991; 36:161-195.

10. Shields CL, Shields JA. Recent developments in the management of choroidal melanoma. Curr Opin Ophthalmol, 2004; 15: 244-251.

11. Shields CL, Shields JA, DePotter P, Cater J, Tardio D, Barrett J. Diffuse choroidal melanoma: Clinical features predictive of metastasis. Arch Ophthalmol, 1996;114:956-63.

12. Shields CL, Demirci H, Dai V. Marr BP, Mashayekhi A, Materin MA , Manquez ME, Shields JA. Intravitreal triamcinolone acetonide for radiation maculopathy following plaque radiotherapy for choroidal melanoma. Submitted for publication.

13. Shields CL, Shields JA, Gross N, Schwartz G, Lally S. Survey of 520 uveal metastases. Ophthalmology, 1997;104:1265-76.

14. Manquez ME, Shields CL, Karatza EC, Shields JA. Regression of choroidal metastases from breast carcinoma using aromatase inhibitors. Br J Ophthalmol 2005;89:776-7

15. Shields CL, Honavar SG, Shields JA, Cater J, Demirci H. Circumscribed choroidal hemangioma. Clinical manifestations and factors predictive of visual outcome in 200 consecutive cases. Ophthalmology 2001;108:2237-48

16. Mashayekhi A, Shields CL. Circumscribed choroidal hemangioma. Curr Opin Ophthalmol 2003; 14: 142-9.

17. Shields JA, Shields CL, Materin MA, Marr BP, Demirci H, Mashayekhi A. Changing concepts in management of circumscribed choroidal hemangioma. The 2003 J. Howard Stokes Lecture, part 1. Oph Surg Lasers 2004;35:383-393.

18. Materin MA, Shields CL, Marr BP, Shields JA. Restoration of anatomic fovea following photodynamic therapy (PDT) for circumscribed choroidal hemangioma. Submitted for publication.

19. Shields CL, Materin MA, Marr BP, Mashayekhi A, Shields JA. Resolution of advanced cystoid macular edema following photodynamic therapy of choroidal hemangioma, Ophthalmic Surg Las Imaging 2004; in press.

20. Gass JD, Guerry RK, Jack RL, Harris G. Choroidal Osteoma. Arch Ophthalmol 1978;96:428-435.

21. Shields CL, Shields JA, Augsburger JJ. Choroidal osteoma. Surv Ophthalmol 1988;33:17-27.

22. Aylward GW, Chang TS, Pautler SE, Gass JD. A long-term follow-up of choroidal osteoma. Arch Ophthalmol 1998;116:1337-1341.

23. Shields CL, Sun H, Demirci H, Shields JA. Choroidal osteoma: Factors predictive of tumor growth, tumor decalcification, choroidal neovascularization, and visual outcome in 74 eyes. Submitted for publication.

24. Ide T, Ohguro N, Hayashi A, et al. Optical coherence tomography patterns of choroidal osteoma. Am J Ophthalmol 2000; 130: 131-4.

25. Fukasawa A, Iijima H. Optical coherence tomography of choroidal osteoma. Am J Ophthalmol. 2002;133:419-21.

26. Shields JA, Shields CL, Gunduz K, Eagle RC Jr. Neoplasms of the retinal pigment epithelium. The 1998 Albert Ruedemann Sr. Memorial Lecture. Part 2. Arch Ophthalmol 1999;117:601-8.

27. Shields CL, Mashayekhi A, Ho T, Cater J, Shields JA. Solitary congenital hypertrophy of the retinal pigment epithelium: Clinical features and frequency of enlargement in 330 patients. Ophthalmology 2003;110:1968-76.

28. Shields JA, Shields CL, Singh AD. Acquired tumors arising from congenital hypertrophy of the retinal pigment epithelium. Arch Ophthalmol 2000;118:637-41.

29. Shields CL, Materin MA, Walker C, Shields JA. Retinal thinning and photoreceptor attenuation overlying congenital hypertrophy of the retinal pigment epithelium. Submitted for publication.

30. Shields CL, Shields JA, Marr BP, Sperber DE, Gass JDM. Congenital simple hamartoma of the retinal pigment epithelium. A study of five cases. Ophthalmology 2003;110:1005-11.

31. Shields CL, Materin MA, Karatza E, Shields JA. Optical coherence tomography (OCT) of congenital simple hamartoma of the retinal pigment epithelium. Retina 2004;24:327-8.

32. Schachat AP, Shields JA, Fine SL, Sanborn GE, Weingeist TA, Valenzuela RE, Brucker AJ, the Macula Society Research Committee. Combined hamartomas of the retina and retinal pigment epithelium. Ophthalmology 1984; 91: 1609-14.

33. Ting TD, McCuen BW 2nd, Fekrat S. Combined hamartoma of the retina and retinal pigment epithelium: optical coherence tomography. Retina. 2002;22:98-101.

34. Shields CL, Mashayekhi A, Dai VD, Materin MA, Shields JA. Optical coherence tomography findings of combined hamartoma of the retinal pigment epithelium in 11 patients. Submitted.

35. Shields CL, Mashayekhi A, Luo CK, Materin MA, Shields JA. Optical coherence tomography in children. Analysis of 44 eyes with intraocular tumors and simulating conditions. J Ped Ophthalmol Strabism 2004;41:338-44.

36. Stallman JB. Visual improvement after pars plana vitrectomy and membrane peeling for vitreoretinal traction associated with combined hamartoma of the retina and retinal pigment epithelium. Retina. 2002; 22: 101-4.

37. Shields JA, Shields CL. Tumors of the retina and optic disc. In Regillo CD, Brown GC, Flynn HW Jr, eds. Vitreoretinal Disease. The Essentials. New York: Thieme Medical Publisheres, Inc, 1999. pp 439-54

38. Shields CL, Shields JA. Phakomatoses. In Regillo CD, Brown GC, Flynn HW Jr, eds. Vitreoretinal Disease. The Essentials. New York: Thieme Medical Publisheres, Inc, 1999. pp 377-90.

39. Singh AD, Shields CL, Shields JA. Major review: Von Hippel-Lindau disease. Surv Ophthalmol 2001;46:117-142.

40. Materin MA, Shields CL, Marr BP, Demirci H, Shields JA. Retinal racemose hemangioma. Retina 2005; in press.

41. Shah GK, Shields JA, Lanning R. Branch retinal vein obstruction secondary to retinal arteriovenous communication. Am J Ophthalmol, 1998;126:446-8.

42. Shields CL, Shields JA. Recent developments in the management of retinoblastoma. J Ped Ophthalmol Strabismus 1999;36:8-18.

43. Shields CL, Meadows AT, Leahey AM, Shields JA. Continuing challenges in the management of retinoblastoma with chemotherapy. Editorial. Retina 2005; in press..

44. Mashayekhi A, Shields CL, Eagle RC Jr, Shields JA. Cavitary changes in retinoblastoma. Relationship to chemoresistence. Ophthalmology 2005; in press.

45. Shields CL, Materin MA, Shields JA. Restoration of foveal anatomy and function following chemoreduction for bilateral retinoblastoma with total retinal detachment. Arch Ophthalmol 2005;123:1610-3

46. Shields JA, Demirci H, Mashayekhi A, Shields CL. Melanocytoma of the optic disc in 115 cases. The 2004 Samuel Johnson Memorial Lecture. Ophthalmology 2004;111:1739-46.